Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1906 1
1909 3
1966 1
1971 1
1974 1
1975 1
1976 1
1977 4
1978 1
1979 5
1980 5
1981 6
1982 4
1983 3
1984 3
1985 4
1986 2
1987 3
1988 3
1989 2
1990 1
1991 5
1992 2
1993 1
1994 4
1995 2
1996 4
1997 7
1998 7
1999 13
2000 5
2001 11
2002 10
2003 4
2004 13
2005 9
2006 12
2007 13
2008 13
2009 15
2010 22
2011 27
2012 24
2013 33
2014 36
2015 31
2016 32
2017 34
2018 34
2019 35
2020 54
2021 38
Text availability
Article attribute
Article type
Publication date

Search Results

542 results
Results by year
Filters applied: . Clear all
Page 1
Targeting potential drivers of COVID-19: Neutrophil extracellular traps.
Barnes BJ, Adrover JM, Baxter-Stoltzfus A, Borczuk A, Cools-Lartigue J, Crawford JM, Daßler-Plenker J, Guerci P, Huynh C, Knight JS, Loda M, Looney MR, McAllister F, Rayes R, Renaud S, Rousseau S, Salvatore S, Schwartz RE, Spicer JD, Yost CC, Weber A, Zuo Y, Egeblad M. Barnes BJ, et al. Among authors: spicer jd. J Exp Med. 2020 Jun 1;217(6):e20200652. doi: 10.1084/jem.20200652. J Exp Med. 2020. PMID: 32302401 Free PMC article.
The National Lung Matrix Trial of personalized therapy in lung cancer.
Middleton G, Fletcher P, Popat S, Savage J, Summers Y, Greystoke A, Gilligan D, Cave J, O'Rourke N, Brewster A, Toy E, Spicer J, Jain P, Dangoor A, Mackean M, Forster M, Farley A, Wherton D, Mehmi M, Sharpe R, Mills TC, Cerone MA, Yap TA, Watkins TBK, Lim E, Swanton C, Billingham L. Middleton G, et al. Among authors: spicer j. Nature. 2020 Jul;583(7818):807-812. doi: 10.1038/s41586-020-2481-8. Epub 2020 Jul 15. Nature. 2020. PMID: 32669708 Free PMC article. Clinical Trial.
SMARCA4 loss is synthetic lethal with CDK4/6 inhibition in non-small cell lung cancer.
Xue Y, Meehan B, Fu Z, Wang XQD, Fiset PO, Rieker R, Levins C, Kong T, Zhu X, Morin G, Skerritt L, Herpel E, Venneti S, Martinez D, Judkins AR, Jung S, Camilleri-Broet S, Gonzalez AV, Guiot MC, Lockwood WW, Spicer JD, Agaimy A, Pastor WA, Dostie J, Rak J, Foulkes WD, Huang S. Xue Y, et al. Among authors: spicer jd. Nat Commun. 2019 Feb 4;10(1):557. doi: 10.1038/s41467-019-08380-1. Nat Commun. 2019. PMID: 30718506 Free PMC article.
Tisotumab Vedotin in Previously Treated Recurrent or Metastatic Cervical Cancer.
Hong DS, Concin N, Vergote I, de Bono JS, Slomovitz BM, Drew Y, Arkenau HT, Machiels JP, Spicer JF, Jones R, Forster MD, Cornez N, Gennigens C, Johnson ML, Thistlethwaite FC, Rangwala RA, Ghatta S, Windfeld K, Harris JR, Lassen UN, Coleman RL. Hong DS, et al. Among authors: spicer jf. Clin Cancer Res. 2020 Mar 15;26(6):1220-1228. doi: 10.1158/1078-0432.CCR-19-2962. Epub 2019 Dec 3. Clin Cancer Res. 2020. PMID: 31796521 Free article. Clinical Trial.
A multicentre randomised phase III trial comparing pembrolizumab versus single-agent chemotherapy for advanced pre-treated malignant pleural mesothelioma: the European Thoracic Oncology Platform (ETOP 9-15) PROMISE-meso trial.
Popat S, Curioni-Fontecedro A, Dafni U, Shah R, O'Brien M, Pope A, Fisher P, Spicer J, Roy A, Gilligan D, Gautschi O, Nadal E, Janthur WD, López Castro R, García Campelo R, Rusakiewicz S, Letovanec I, Polydoropoulou V, Roschitzki-Voser H, Ruepp B, Gasca-Ruchti A, Peters S, Stahel RA. Popat S, et al. Among authors: spicer j. Ann Oncol. 2020 Dec;31(12):1734-1745. doi: 10.1016/j.annonc.2020.09.009. Epub 2020 Sep 22. Ann Oncol. 2020. PMID: 32976938 Clinical Trial.
Neutrophil extracellular traps in cancer progression.
Cools-Lartigue J, Spicer J, Najmeh S, Ferri L. Cools-Lartigue J, et al. Among authors: spicer j. Cell Mol Life Sci. 2014 Nov;71(21):4179-94. doi: 10.1007/s00018-014-1683-3. Epub 2014 Jul 29. Cell Mol Life Sci. 2014. PMID: 25070012 Free PMC article. Review.
542 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page